Tag Archives: Neelie Kroes

"Data is the New Oil": Open Access to Sweep Europe?

The European Commission has followed the UK government’s plans to make all publicly funded scientific research available for free, announcing that it will improve access to scientific information in Europe. The UK’s proposal, on the table since last year, was confirmed on Monday by Universities and Science Minister David Willetts. The scheme will make research papers [...]
Posted in Europe, Guest Blog | Also tagged , , , , , , | 1 Comment

Europe: Not Out of the Antitrust Woods Yet

Guest blog from Pharm Exec Europe’s Brussels correspondent, Reflector. The new year has started with a grim reminder that last year’s heat over competition in the European pharmaceutical sector has not been dissipated by the winter’s frosts. Before January was a week old, the European Commission (EC) announced that it had opened a formal antitrust [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , , | Leave a comment

The EC Admonishes European Pharma, European Pharma Celebrates

Despite the rhetoric, the climax of the European Commission’s antitrust investigations — instigated with dawn raids on the major pharma companies by EC Competition Commissioner Neelie Kroes last year — has been more of a whimper than a bang. Pharm Exec Europe’s EU correspondent Reflector goes so far as to say “Big Pharma is not opening [...]
Posted in Global, Regulatory | Also tagged , , , , , , , , | Leave a comment

Pharma Accused of Keeping Good Generics Down

Image via Wikipedia The European Commission has accused the pharmaceutical industry of delaying the entry of generic drugs to the market. As a result, it intends to step up its scrutiny of the sector under EU antitrust law. “We must have more competition and less red tape in pharmaceuticals,” claimed Competition Commissioner Neelie Kroes. “The inquiry [...]
Posted in Global, News | Also tagged , , , , , , | 1 Comment